Mississauga, ON -- (SBWIRE) -- 11/20/2014 -- AllPennyStocks.com Media, Inc. (http://www.AllPennyStocks.com/) announces its latest article titled “Impressive Gain in Nuvilex Shares Following Preclinical Data.”
Companies mentioned in this article include Nuvilex (OTCQB: NVLX).
Article Excerpt:
Nuvilex (OTCQB: NVLX) surged more than 100% this year, in stark contrast to the underperforming healthcare sector. The company got another boost Wednesday after announcing preliminary data from the preclinical study of its pancreatic cancer treatment on ascites fluid formation.
The data came from a preclinical animal study and indicated that treatment with Nuvilex’s live-cell encapsulation technology called Cell-in-a-Box® plus ifosfamide produces a significant survival advantage in tumor-bearing animals when compared to non-treated animals. In fact, the data suggests that Nuvilex is at least as good as cisplatin, which is the current standard of care for ovarian cancer.
The full version of this article can be found at:
http://www.allpennystocks.com/aps_us/special-reports/489/impressive-gain-in-nuvilex-shares-following-preclinical-data.htm
About AllPennyStocks.com
AllPennyStocks.com is focused on the small-cap / penny stock market and has become a reputable name in the investment community. AllPennyStocks.com runs a Canadian and US site to provide investors in Canada as well as the United States with informative and unique content and information. AllPennyStocks.com runs daily technical penny stocks to watch, has a daily market write-up, provides company spotlights, runs unique most active pages strictly for penny stocks trading on the TSX, TSX Venture, NASDAQ and OTC BB, and much more information for the average investor.
AllPennyStocks.com also runs an email newsletter that aims to uncover stocks that are still under the radar of most investors. Criteria AllPennyStocks.com looks for includes strong revenues, a seasoned management, innovative business plans, among many others. AllPennyStocks.com also looks for companies that announce breaking news, recent 52-week highs/lows, technical breakouts, and other favorable corporate information.
Investors are encouraged to subscribe to the AllPennyStocks.com FREE e-mail newsletter and see what tens of thousands of other investors have already been receiving since 1999. Investors can receive their free newsletter subscription by clicking here: http://www.allpennystocks.com/aps_common/newsletter_free.asp.
Contact:
AllPennyStocks.com Media, Inc.
Peter Szafranski -- President
Phone: (905) 361-5680
E-Mail: peter@allpennystocks.com
Websites: http://www.allpennystocks.com / http://www.bullishinvestor.com
Note: AllPennyStocks.com has not received compensation for carrying the above-mentioned company; a full disclaimer can be viewed here: http://www.allpennystocks.com/aps_common/disclaimer.asp.